Bigul

Eris Lifesciences Ltd - 540596 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DEPOSITORIES AND PARTICIPANTS) REGULATIONS, 2018 FOR THE QUARTER ENDED SEPTEMBER 2021
07-10-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
07-10-2021

Eris Lifesciences Q2 PAT seen up 8.5% YoY to Rs 116.9 cr: Prabhudas Lilladher

Net Sales are expected to increase by 11 percent Y-o-Y (up 5.1 percent Q-o-Q) to Rs 361.1 crore, according to Prabhudas Lilladher.
06-10-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
30-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
29-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
27-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

Allotment of equity shares pursuant to ESOP-2017 Scheme
24-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Closure of Trading Window

INTIMATION OF CLOSURE OF TRADING WINDOW
22-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS.
21-09-2021
Bigul

Eris Lifesciences Ltd - 540596 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
07-09-2021
Next Page
Close

Let's Open Free Demat Account